Publications by authors named "Ron C Kelly"

Claim this Profile
D
Data-driven approach to mitigate quality impact of hygroscopic pharmaceutical raw materials throughout the supply chain.
Mary K Chaves, Ron C Kelly, Jacqueline E Milne, Susan E Burke

Pharm Dev Technol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.
Gwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, Brian Belmontes, Gordon Moody, Ron C Kelly

J Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of the Measurement of Bulk/Tapped Density of Pharmaceutical Powders Between Pharmaceutical Laboratories.
Ilgaz Akseli, Jon Hilden, Jeffrey M Katz, Ron C Kelly, Timothy T Kramer

J Pharm Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of Powder X-Ray Diffraction in Small Molecule Pharmaceuticals: Achievements and Aspirations.
Naveen K Thakral, Roger L Zanon, Ron C Kelly, Seema Thakral

J Pharm Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing the Impact of Physiologically Based Oral Absorption Modeling and Simulation.
John I Chung, Ron C Kelly, Jan Wahlstrom, Benjamin Wu, Tian Wu

J Pharm Sci· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salt disproportionation: A material science perspective.
Naveen K Thakral, Ron C Kelly

Int J Pharm· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430).
Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, Minna Bui, Iain D G Campuzano, Ron C Kelly

J Med Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors.
Youngsook Shin, Julia Suchomel, Mario Cardozo, Jason Duquette, Xiao He, Ron C Kelly

J Med Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease.
Timothy D Cushing, Xiaolin Hao, Youngsook Shin, Kristin Andrews, Matthew Brown, Ron C Kelly

J Med Chem· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved pharmacokinetics of AMG 517 through co-crystallization part 2: analysis of 12 carboxylic acid co-crystals.
Mary K Stanton, Ron C Kelly, Adria Colletti, Meghan Langley, Eric J Munson

J Pharm Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved pharmacokinetics of AMG 517 through co-crystallization. Part 1: comparison of two acids with corresponding amide co-crystals.
Mary K Stanton, Ron C Kelly, Adria Colletti, Y-H Kiang, Meghan Langley

J Pharm Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.
Ann Newman, David Engers, Simon Bates, Igor Ivanisevic, Ron C Kelly

J Pharm Sci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of defects and amorphous structure produced in raffinose pentahydrate upon dehydration.
Simon Bates, Ron C Kelly, Igor Ivanisevic, Paul Schields, George Zografi

J Pharm Sci· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis